Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | PEPD | P12955 | 1/20 | 0.34 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.34 |
| ▸ | CPT1A | P50416 | 3/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28570568 | 1.00 | SRC (0.35) | SRCPEPDXPNPEP1CPT1ARIPK1 | |
| SCHEMBL28576468 | 0.87 | PEPD (0.36) | SRCPEPDXPNPEP1MAPK1 | |
| SCHEMBL28576472 | 0.87 | PEPD (0.36) | SRCPEPDXPNPEP1MAPK1 | |
| SCHEMBL5649142 | 0.71 | RIPK1 (0.42) | CPT1ARIPK1 | |
| SCHEMBL5649137 | 0.71 | RIPK1 (0.42) | CPT1ARIPK1 | |
| SCHEMBL5316207 | 0.70 | CPT1A (0.40) | CPT1A | |
| SCHEMBL28887450 | 0.70 | SCD5 (0.34) | SRCCPT1ARIPK1 | |
| SCHEMBL20187292 | 0.70 | SCD5 (0.34) | SRCCPT1ARIPK1 | |
| SCHEMBL28887421 | 0.69 | RIPK1 (0.35) | CPT1ARIPK1MAPK1 | |
| SCHEMBL20187368 | 0.69 | RIPK1 (0.35) | CPT1ARIPK1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112812074-B | Tetrazine compound and preparation method and application thereof | 四川大学华西医院 | 2022-06-14 | — | — | CN | disclosed |
| CN-112812074-A | Tetrazine compound and preparation method and application thereof | 四川大学华西医院 | 2021-05-18 | — | — | CN | disclosed |